Currently out of the existing stock ratings of David Styblo, 53 are a BUY (80.3%), 13 are a HOLD (19.7%).

David Styblo

Work Performance Price Targets & Ratings Chart

Analyst David Styblo, carries an average stock price target met ratio of 89.21% that have a potential upside of 36.88% achieved within 482 days. Previously, David Styblo worked at JEFFERIES.

David Styblo’s has documented 114 price targets and ratings displayed on 7 stocks. The coverage was on Financial Services, Healthcare, Industrials sectors.

Most recent stock forecast was given on MGLN, Magellan Health at 15-Jan-2021.

Wall Street Analyst David Styblo

Analyst best performing recommendations are on EHTH (EHEALTH).
The best stock recommendation documented was for EHTH (EHEALTH) at 2/27/2017. The price target of $11.5 was fulfilled within 1 day with a profit of $0.23 (1.96%) receiving and performance score of 19.61.

Average potential price target upside

AON Aon PLC EHTH eHealth MGLN Magellan Health MMS Maximus TVTY Tivity Health WLTW Willis Towers Watson Public Company WTW Willis Towers Watson PLC

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$414

$4.88 (1.19%)

$411

26 days ago
(05-Feb-2025)

5/8 (62.5%)

$31.61 (8.27%)

71

Buy

$445

$35.88 (8.77%)

1 months ago
(03-Feb-2025)

23/27 (85.19%)

$70.12 (18.70%)

128

Hold

$384

$-25.12 (-6.14%)

$335

1 months ago
(03-Feb-2025)

14/14 (100%)

$9.12 (2.43%)

73

$420

$33.49 (8.66%)

$384

1 months 23 days ago
(08-Jan-2025)

4/5 (80%)

$67.47 (19.14%)

44

Buy

$394

$-15.12 (-3.70%)

$379

2 months ago
(03-Jan-2025)

10/10 (100%)

$40.66 (11.51%)

154

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by David Styblo?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?